BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
1498596
Number of visits today
54
Number of downloads
1161698
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Louie AD, Huntington K, Carlsen L, Zhou L, El-Deiry WS. Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics. Front Pharmacol 2021;12:747194. [PMID: 34737704 DOI: 10.3389/fphar.2021.747194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Seyhan AA, Carini C. Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response Rates. Int J Mol Sci 2022;24. [PMID: 36613491 DOI: 10.3390/ijms24010041] [Reference Citation Analysis]
2 Sarvari P, Sarvari P, Ramírez-díaz I, Mahjoubi F, Rubio K. Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer. IJMS 2022;23:9521. [DOI: 10.3390/ijms23179521] [Reference Citation Analysis]
3 Mao XY, Perez-Losada J, Abad M, Rodríguez-González M, Rodríguez CA, Mao JH, Chang H. iCEMIGE: Integration of CEll-morphometrics, MIcrobiome, and GEne biomarker signatures for risk stratification in breast cancers. World J Clin Oncol 2022; 13(7): 616-629 [DOI: 10.5306/wjco.v13.i7.616] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pu J, Yu H, Guo Y. A Novel Strategy to Identify Prognosis-Relevant Gene Sets in Cancers. Genes 2022;13:862. [DOI: 10.3390/genes13050862] [Reference Citation Analysis]
5 Firdous S, Srivastava SK, Saha S. Cancer Biomarkers in the Era of Systems Biology. Systems Biomedicine Approaches in Cancer Research 2022. [DOI: 10.1007/978-981-19-1953-4_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345